News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Oramed Pharmaceuticals Inc. (ORMP.OB) to Present Findings on Oral Insulin to the American Diabetes Association


6/24/2013 6:42:23 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

JERUSALEM, June 21, 2013 /PRNewswire via COMTEX/ -- Oramed Pharmaceuticals Inc. (nasdaqcm:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it will be presenting its abstract titled, "Dose response to oral insulin capsules in fasting, healthy subjects," at the 73rd Scientific Sessions of the American Diabetes Association, on June 21st through 25th, 2013, in Chicago, Illinois, USA.

Help employers find you! Check out all the jobs and post your resume.

Read at Market Watch

Related News

comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES